Dis-Chem Pharmacies Ltd
JSE:DCP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
ZA |
|
Engie SA
PAR:ENGI
|
FR |
|
AMP Ltd
ASX:AMP
|
AU |
|
M
|
Manulife Financial Corp
NYSE:MFC
|
CA |
|
K
|
Kraft Heinz Co
BMV:KHC
|
US |
|
T
|
Teledyne Technologies Inc
F:TYZ
|
US |
|
Star Entertainment Group Ltd
ASX:SGR
|
AU |
|
Caltagirone Editore SpA
MIL:CED
|
IT |
|
Mitsubishi Corp
TSE:8058
|
JP |
|
Extreme Networks Inc
NASDAQ:EXTR
|
US |
|
D
|
Diamondback Energy Inc
SWB:7DB
|
US |
|
Carlisle Companies Inc
NYSE:CSL
|
US |
|
Supriya Lifescience Ltd
NSE:SUPRIYA
|
IN |
|
Credo Technology Group Holding Ltd
NASDAQ:CRDO
|
KY |
|
N
|
Neschen AG
F:NSN
|
DE |
|
B
|
B2holding ASA
OSE:B2H
|
NO |
|
U
|
Unilever PLC
OTC:UNLYF
|
UK |
|
B
|
BTS Group Holdings PCL
SET:BTS
|
TH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DCP's stock price target?
Not Available
DCP does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Dis-Chem Pharmacies Ltd?
Projected CAGR
10%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Dis-Chem Pharmacies Ltd?
Projected CAGR
9%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Dis-Chem Pharmacies Ltd?
Projected CAGR
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 13%.
